These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21250873)

  • 1. Blood coagulation factor Xa as an emerging drug target.
    Borensztajn K; Spek CA
    Expert Opin Ther Targets; 2011 Mar; 15(3):341-9. PubMed ID: 21250873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor Xa: at the crossroads between coagulation and signaling in physiology and disease.
    Borensztajn K; Peppelenbosch MP; Spek CA
    Trends Mol Med; 2008 Oct; 14(10):429-40. PubMed ID: 18774340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?
    Borensztajn K; Peppelenbosch MP; Spek CA
    Trends Pharmacol Sci; 2009 Jan; 30(1):8-16. PubMed ID: 19058861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation.
    Borensztajn K; Stiekema J; Nijmeijer S; Reitsma PH; Peppelenbosch MP; Spek CA
    Am J Pathol; 2008 Feb; 172(2):309-20. PubMed ID: 18202198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation factor Xa inhibits cancer cell migration via protease-activated receptor-1 activation.
    Borensztajn K; Bijlsma MF; Reitsma PH; Peppelenbosch MP; Spek CA
    Thromb Res; 2009 Jun; 124(2):219-25. PubMed ID: 19250659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.
    Rana S; Yang L; Hassanian SM; Rezaie AR
    J Cell Biochem; 2012 Mar; 113(3):977-84. PubMed ID: 22034092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation signalling following tissue injury: focus on the role of factor Xa.
    Krupiczojc MA; Scotton CJ; Chambers RC
    Int J Biochem Cell Biol; 2008; 40(6-7):1228-37. PubMed ID: 18420447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation-independent effects of thrombin and Factor Xa: role of protease-activated receptors in pulmonary hypertension.
    Joseph C; Berghausen EM; Behringer A; Rauch B; Ten Freyhaus H; Gnatzy-Feik LL; Krause M; Wong DWL; Boor P; Baldus S; Vantler M; Rosenkranz S
    Cardiovasc Res; 2022 Dec; 118(16):3225-3238. PubMed ID: 35104324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.
    Spronk HM; de Jong AM; Crijns HJ; Schotten U; Van Gelder IC; Ten Cate H
    Cardiovasc Res; 2014 Mar; 101(3):344-51. PubMed ID: 24385341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation cascade activation causes CC chemokine receptor-2 gene expression and mononuclear cell activation in hemodialysis patients.
    Pertosa G; Simone S; Soccio M; Marrone D; Gesualdo L; Schena FP; Grandaliano G
    J Am Soc Nephrol; 2005 Aug; 16(8):2477-86. PubMed ID: 15976001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling.
    Feistritzer C; Lenta R; Riewald M
    J Thromb Haemost; 2005 Dec; 3(12):2798-805. PubMed ID: 16359518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of protease-activated receptors PAR-1 and PAR-2 in the repair of 16HBE 14o(-) epithelial cell monolayers in vitro.
    Ewen D; Clarke SL; Smith JR; Berger C; Salmon G; Trevethick M; Shute JK
    Clin Exp Allergy; 2010 Mar; 40(3):435-49. PubMed ID: 20210813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation cascade proteases and tissue fibrosis.
    Chambers RC; Laurent GJ
    Biochem Soc Trans; 2002 Apr; 30(2):194-200. PubMed ID: 12023850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox regulation of human protease-activated receptor-2 by activated factor X.
    Jobi K; Rauch BH; Dangwal S; Freidel K; Doller A; Eberhardt W; Fischer JW; Schrör K; Rosenkranz AC
    Free Radic Biol Med; 2011 Nov; 51(9):1758-64. PubMed ID: 21871560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?
    Papadaki S; Tselepis AD
    Angiology; 2019 Nov; 70(10):896-907. PubMed ID: 31010298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation Factor Xa Induces Proinflammatory Responses in Cardiac Fibroblasts via Activation of Protease-Activated Receptor-1.
    D'Alessandro E; Scaf B; Munts C; van Hunnik A; Trevelyan CJ; Verheule S; Spronk HMH; Turner NA; Ten Cate H; Schotten U; van Nieuwenhoven FA
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue.
    Bukowska A; Zacharias I; Weinert S; Skopp K; Hartmann C; Huth C; Goette A
    Eur J Pharmacol; 2013 Oct; 718(1-3):114-23. PubMed ID: 24041930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin and factor Xa link the coagulation system with liver fibrosis.
    Dhar A; Sadiq F; Anstee QM; Levene AP; Goldin RD; Thursz MR
    BMC Gastroenterol; 2018 May; 18(1):60. PubMed ID: 29739329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review.
    Pinto DJ; Qiao JX; Knabb RM
    Expert Opin Ther Pat; 2012 Jun; 22(6):645-61. PubMed ID: 22655676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multivalent activity of the tissue factor-thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention.
    Mitroulis I; Kambas K; Anyfanti P; Doumas M; Ritis K
    Expert Opin Ther Targets; 2011 Jan; 15(1):75-89. PubMed ID: 21062231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.